VSL#3 induces and maintains short-term clinical response in patients with active microscopic colitis: a two-phase randomised clinical trial

BACKGROUND: The probiotic mixture VSL#3 has proven efficacious in inflammatory bowel diseases and irritable bowel syndrome; however, its efficacy in microscopic colitis (MC) is being investigated. OBJECTIVE: To evaluate the safety and efficacy of a multistrain probiotic, VSL#3, in inducing clinical...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Open Gastroenterol
Egile Nagusiak: Rohatgi, Sarika, Ahuja, Vineet, Makharia, Govind K, Rai, Tarun, Das, Prasenjit, Dattagupta, Siddharth, Mishra, Veena, Garg, Sushil Kumar
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2015
Gaiak:
Inflammatory Bowel Disease
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599154/
https://ncbi.nlm.nih.gov/pubmed/26462271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2014-000018
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak